PharmEasy parent API Holdings has introduced an AI-based physiotherapy platform to expand its digital healthcare offerings. The move aims to boost margins and customer retention by cross-selling high-value services. Investors are focused on the company’s ongoing efforts to improve financial performance after narrowing its net losses in the recent fiscal year.
PharmEasy, the digital healthcare platform owned by API Holdings, has launched an AI-driven online physiotherapy service. This new platform uses smartphone cameras to analyze a patient’s posture and movement, which is then used to create personalized recovery plans. The system is designed to treat various musculoskeletal conditions, such as knee and back pain, while allowing human physiotherapists to monitor and guide the patient through video consultations.
This launch reflects a clear strategy to evolve beyond the company's core medicine delivery business. While pharmacy sales provide high volume, profit margins are often thin. By adding services like diagnostics and physiotherapy, the company aims to become a more comprehensive healthcare partner for its customers. The goal is to improve customer lifetime value, as patients often require multiple sessions for recovery, creating a recurring service relationship.
For investors tracking the company's progress, this shift is critical for the path to profitability. API Holdings reported operating revenue of approximately ₹5,872 crore for the fiscal year 2025. While revenue growth has stabilized, the company has made progress in controlling costs, with net losses narrowing by 38% to ₹1,572 crore during the same period. The management is now focused on operational efficiency rather than aggressive, cash-burning expansion.
The company faces significant challenges in this new segment. It competes with established digital health platforms like Fix Health, FlexifyMe, and Phyt.health. Furthermore, because API Holdings is an unlisted company, its shares are only traded in the private market, which means there is limited liquidity and transparency compared to publicly traded stocks. Scaling this service while maintaining quality and ensuring customer adoption remains a key execution risk.
The main area to watch will be how quickly the company can scale this service and whether it begins to show a measurable positive impact on profit margins. Success will depend on the company’s ability to effectively cross-sell these services to its massive existing user base, which remains its primary advantage over newer startups in the space.